Related Experiment Video
Updated: Jan 4, 2026
07:40
Multi-Modal Home Sleep Monitoring in Older Adults
Published on: January 26, 2019
8.1K
Optimising medication management for polymedicated home-dwelling older adults with multiple chronic conditions: a
Filipa Pereira1,2, Pauline Roux3, Marie Santiago-Delefosse3
1School of Health Sciences, HES-SO Valais-Wallis, Sion, Switzerland filipa.pereira@hevs.ch.
BMJ Open
|October 31, 2019
Summary
This study explores medication management in older adults with multiple chronic conditions to reduce hospitalizations. Findings will inform a new model to improve care and prevent adverse health outcomes for polymedicated individuals.
Area of Science:
- Gerontology and Public Health
- Health Services Research
- Medication Management
Background:
- Optimal medication management is crucial for home-dwelling older adults with multiple chronic conditions (OAMCC) to maintain quality of life.
- Medication-related problems (MRPs) contribute significantly to emergency department visits and hospitalizations in OAMCC, yet underlying reasons are poorly understood.
Purpose of the Study:
- To investigate the current medication management practices of polymedicated, home-dwelling OAMCC.
- To propose an innovative, integrated model for supporting medication management and preventing adverse health outcomes in this population.
Main Methods:
- A mixed-methods explanatory sequential design combining quantitative analysis of electronic health records (N ≈ 50,000) and qualitative interviews (N ≈ 30) with OAMCC and caregivers.
- Quantitative phase: Identify risk profiles for hospitalization, ED visits, readmission, institutionalization, or death based on patient, medication, and environmental factors.
- Qualitative phase: Explore medication management experiences and perspectives of OAMCC and their formal/informal caregivers.
Main Results:
- (Pending study completion) Identification of distinct profiles of OAMCC at risk due to medication management issues.
- (Pending study completion) In-depth understanding of the practical challenges and experiences of medication management from patient and caregiver viewpoints.
Conclusions:
- (Pending study completion) Development of an innovative, integrated model for medication management tailored to OAMCC.
- (Pending study completion) Potential to improve clinical and medication pathways, reduce adverse health events, and support aging in place for OAMCC.
Keywords:
home-dwelling older adultshospitalisationmedication managementmedication-related problemsmixed-methods researchmultiple chronic conditionspolymedicationprotocolretrospective reviewMore Related Videos
11:21Methodology for Establishing a Community-Wide Life Laboratory for Capturing Unobtrusive and Continuous Remote Activity and Health Data
Published on: July 27, 2018
8.6K
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.9K
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
191
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
191
01:28Dosage Regimens: Designs and Approaches
224
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
224
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
191
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
191
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
210
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
210
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
169
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
169
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
162
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
162